Clinical trial
CIVILIAN Study in Femoropopliteal Artery Occlusion Disease
NCT05473884 is registered in ClinicalTrials.gov with Shanghai Pudong Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CIVILIAN Study in Femoropopliteal Artery Occlusion Disease
- Lead sponsor
- Shanghai Pudong Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2022
- Completion date
- May 31, 2024
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis obliterans, femoropopliteal artery occlusion, in-stent restenosis, lesion; vascular